PCBL shares climb 5% on Rs 3,800 cr acquisition; stock target Rs 279, says Nuvama

PCBL shares climb 5% on Rs 3,800 cr acquisition; stock target Rs 279, says Nuvama

PCBL’s focus on driving products catering to batteries for EV, coupled with this ACPL acquisition, would rerate its business model and margin profile, Nuvama said.

Advertisement
PCBL: As acquisition will be funded via debt, internal cash flows, Nuvama expects year-end debt for PCBL to go up to Rs 4,000 crore with expected average interest cost of 9-9.5 per cent.PCBL: As acquisition will be funded via debt, internal cash flows, Nuvama expects year-end debt for PCBL to go up to Rs 4,000 crore with expected average interest cost of 9-9.5 per cent.
Amit Mudgill
  • Nov 29, 2023,
  • Updated Nov 29, 2023 9:32 AM IST

Shares of PCBL Ltd (erstwhile  Phillips Carbon Black Ltd) climbed over 3 per cent in Wednesday's trade after the company board approved the acquisition of Aquapharm Chemicals for a consideration of Rs 3,800 crore. There are hopes that the acquisition would upgrade PCBL's business model, margin profile and drive re-rating on the counter, even as some near-term pressure on balance sheet is likely.  

Advertisement

Following the development, the stock rose 4.6 per cent to hit a high of Rs 266 on BSE. Nuvama Institutional Equities has upped its target on the stock to Rs 279 from Rs 209 earlier.

"We forecast PCBL to be in transition to move up its product basket while continuing to drive share of value added and speciality. Though organically, it is focused on driving share of speciality black versus carbon black, we believe its further focus on driving products catering to batteries for EV coupled with this acquisition would rerate its business model and margin profile. As the stock is trading at a significant discount to speciality chemicals (16x EV/EBITDA versus 6x assigned to PCBL), we value the stock at 8x with a target of Rs 279," Nuvama said while maintaining its ‘BUY’ on the stock.

Advertisement

ACPL with FY23 sales and Ebitda of Rs 2,000 crore  and Rs 420 crore is valued at 9.1 times EV/Ebitda. Given the global weakness and margin pressure, Nuvama expects FY24 to see moderation in profitability at Rs 350 crore.

As acquisition will be funded via debt, internal cash flows, Nuvama expects year-end debt for PCBL to go up to Rs 4,000 crore with expected average interest cost of 9-9.5 per cent.

"Though management is confident of the deal being earnings accretive, we expect it to drag earnings near FY24E/25E, given industry weakness. Expect net debt/Ebitda to cross 3.5 times with debt/equity of 1 time in FY24," Nuvama said.

 

 

Also read: Canara Bank shares in focus today as RBI approves stake sale in subsidiary 

Advertisement

 

Also read: Top 10 stocks to watch on November 29 2023: Tata Power, BHEL, ICICI Lombard, Global Health, Wipro and more

Also read: Stock recommendations for November 29, 2023: HCL Tech, Max Financial Services and Praj Industries

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.

Shares of PCBL Ltd (erstwhile  Phillips Carbon Black Ltd) climbed over 3 per cent in Wednesday's trade after the company board approved the acquisition of Aquapharm Chemicals for a consideration of Rs 3,800 crore. There are hopes that the acquisition would upgrade PCBL's business model, margin profile and drive re-rating on the counter, even as some near-term pressure on balance sheet is likely.  

Advertisement

Following the development, the stock rose 4.6 per cent to hit a high of Rs 266 on BSE. Nuvama Institutional Equities has upped its target on the stock to Rs 279 from Rs 209 earlier.

"We forecast PCBL to be in transition to move up its product basket while continuing to drive share of value added and speciality. Though organically, it is focused on driving share of speciality black versus carbon black, we believe its further focus on driving products catering to batteries for EV coupled with this acquisition would rerate its business model and margin profile. As the stock is trading at a significant discount to speciality chemicals (16x EV/EBITDA versus 6x assigned to PCBL), we value the stock at 8x with a target of Rs 279," Nuvama said while maintaining its ‘BUY’ on the stock.

Advertisement

ACPL with FY23 sales and Ebitda of Rs 2,000 crore  and Rs 420 crore is valued at 9.1 times EV/Ebitda. Given the global weakness and margin pressure, Nuvama expects FY24 to see moderation in profitability at Rs 350 crore.

As acquisition will be funded via debt, internal cash flows, Nuvama expects year-end debt for PCBL to go up to Rs 4,000 crore with expected average interest cost of 9-9.5 per cent.

"Though management is confident of the deal being earnings accretive, we expect it to drag earnings near FY24E/25E, given industry weakness. Expect net debt/Ebitda to cross 3.5 times with debt/equity of 1 time in FY24," Nuvama said.

 

 

Also read: Canara Bank shares in focus today as RBI approves stake sale in subsidiary 

Advertisement

 

Also read: Top 10 stocks to watch on November 29 2023: Tata Power, BHEL, ICICI Lombard, Global Health, Wipro and more

Also read: Stock recommendations for November 29, 2023: HCL Tech, Max Financial Services and Praj Industries

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.
Read more!
Advertisement